AVAH Strangle Strategy
AVAH (Aveanna Healthcare Holdings Inc.), in the Healthcare sector, (Medical - Care Facilities industry), listed on NASDAQ.
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis.
AVAH (Aveanna Healthcare Holdings Inc.) trades in the Healthcare sector, specifically Medical - Care Facilities, with a market capitalization of approximately $1.47B, a trailing P/E of 6.12, a beta of 1.93 versus the broader market, a 52-week range of 3.73-10.32, average daily share volume of 1.3M, a public-listing history dating back to 2021, approximately 34K full-time employees. These structural characteristics shape how AVAH stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.93 indicates AVAH has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. The trailing P/E of 6.12 is on the value side, where IV often compresses outside event windows because forward growth expectations are already discounted into the share price.
What is a strangle on AVAH?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current AVAH snapshot
As of May 15, 2026, spot at $7.72, ATM IV 75.10%, IV rank 17.84%, expected move 21.53%. The strangle on AVAH below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on AVAH specifically: AVAH IV at 75.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a AVAH strangle, with a market-implied 1-standard-deviation move of approximately 21.53% (roughly $1.66 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AVAH expiries trade a higher absolute premium for lower per-day decay. Position sizing on AVAH should anchor to the underlying notional of $7.72 per share and to the trader's directional view on AVAH stock.
AVAH strangle setup
The AVAH strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AVAH near $7.72, the first option leg uses a $8.11 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AVAH chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AVAH shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $8.11 | N/A |
| Buy 1 | Put | $7.33 | N/A |
AVAH strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
AVAH strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on AVAH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on AVAH
Strangles on AVAH are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the AVAH chain.
AVAH thesis for this strangle
The market-implied 1-standard-deviation range for AVAH extends from approximately $6.06 on the downside to $9.38 on the upside. A AVAH long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current AVAH IV rank near 17.84% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on AVAH at 75.10%. As a Healthcare name, AVAH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AVAH-specific events.
AVAH strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AVAH positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AVAH alongside the broader basket even when AVAH-specific fundamentals are unchanged. Always rebuild the position from current AVAH chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on AVAH?
- A strangle on AVAH is the strangle strategy applied to AVAH (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With AVAH stock trading near $7.72, the strikes shown on this page are snapped to the nearest listed AVAH chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are AVAH strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the AVAH strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 75.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a AVAH strangle?
- The breakeven for the AVAH strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AVAH market-implied 1-standard-deviation expected move is approximately 21.53%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on AVAH?
- Strangles on AVAH are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the AVAH chain.
- How does current AVAH implied volatility affect this strangle?
- AVAH ATM IV is at 75.10% with IV rank near 17.84%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.